<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02330237</url>
  </required_header>
  <id_info>
    <org_study_id>NGCPP</org_study_id>
    <nct_id>NCT02330237</nct_id>
  </id_info>
  <brief_title>Natural Gels for Treatment of Plaque Psoriasis</brief_title>
  <official_title>Safety and Efficacy of Natural Gel Combination and Hair Mask of Plant Origin in Patients With Psoriasis: A Randomized, Double-Blind, Placebo (Vehicle) Controlled</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Secret of Youth</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Secret of Youth</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the safety and the therapeutic activity of the
      combination of Natural Gel combination and hair mask of plant origin in patients with mild to
      moderate plaque psoriasis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a random, double blind placebo -vehicle- controlled study. Patients recruiting and
      inclusion into the study is well defined. Expert on site monitoring will assure execution of
      all assignments as detailed in the protocol (screening, consent form, double-blind group
      assignment) .

      Statistical analysis:

        -  It is calculated that 52 patients will be needed for this study.

        -  Type I error probability associated with this test is 0.05 .

        -  Uncorrected chi square will be used to assess changes in the measured variables.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Psoriasis Assessment severity index</measure>
    <time_frame>up to 16 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Parapsoriasis</condition>
  <arm_group>
    <arm_group_label>patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>natural gels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>subjects</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>These patients will receive that placebo (vehicle) products.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>natural gels</intervention_name>
    <description>whole fruits and vegetables</description>
    <arm_group_label>patients</arm_group_label>
    <other_name>plant origin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subjects with stable (for at least 6 months), mild to moderate (less than 10% of the
             skin surface area) plaque psoriasis.

          2. Male and female â‰¥ 18 years old.

          3. Subject is capable of giving a written informed consent.

        Exclusion Criteria:

          1. Subjects treated by topical or photo or systemic anti psoriatic therapy during 4 weeks
             prior to the study.

          2. Subjects treated with Biological products for psoriasis for the last 3 months prior to
             starting the present study.

          3. Subjects with any other type of psoriasis but vulgaris (plaque ).

          4. Use of investigational agents &lt; 30 days prior to the study.

          5. Low compliance.

          6. Subjects who are mentally or physically unable to comply with all aspects of the
             study.

          7. Pregnant women.

          8. Known allergic reaction to fragrance or any ingredient of the test products.

          9. Other inflammatory skin disease in the treatment area that may confound the evaluation
             of the psoriasis.

         10. A medical condition that may put the patient at a general risk and therefore would
             prevent participation in the clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Pavlotzky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaim sheba Medical Center, Dept. of Dermatolgy. Tel-Hashomer, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Efraim Ben-Ari, Ph.D.</last_name>
    <phone>+972-54-4773623</phone>
    <email>efraimbenari@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rami Maimon, MBA</last_name>
    <phone>+972-3-6343444</phone>
    <email>rami@s-of-y.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chaim sheba Medical Center, Dept. of Dermatolgy. Tel-Hashomer, Israel</name>
      <address>
        <city>Tel Hasomer</city>
        <state>Ramat-almogi</state>
        <zip>34793</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>EFRAIM BEN-ARI, Ph.D.</last_name>
      <phone>972-54-4773623</phone>
      <email>efraimbenari@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Felix Pavlotsky, MD</last_name>
      <phone>972-528305227</phone>
      <email>felix.pavlotsky@sheba.health.gov.il</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2014</study_first_submitted>
  <study_first_submitted_qc>December 31, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 1, 2015</study_first_posted>
  <last_update_submitted>April 19, 2016</last_update_submitted>
  <last_update_submitted_qc>April 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Psoriasis</mesh_term>
    <mesh_term>Parapsoriasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

